Pharmacology of a new anti-parkinsonian drug: KAO-264.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002375:Catalepsy / Q000139:chemically induced / Q000188:drug therapy; D006220:Haloperidol; D000882:Haplorhini; D006801:Humans; D009184:Mydriatics; D010276:Parasympatholytics / Q000494:pharmacology*; D013876:Thiophenes / Q000494:pharmacology; D014282:Trihexyphenidyl / Q000494:pharmacology; D014326:Tropanes / Q000494:pharmacology*
D009184:Mydriatics; D010276:Parasympatholytics; D013876:Thiophenes; D014326:Tropanes; D014282:Trihexyphenidyl; D001285:Atropine; D006220:Haloperidol